These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 17138801)
1. ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy. ACOG Committee on Obstetric Practice Obstet Gynecol; 2006 Dec; 108(6):1601-3. PubMed ID: 17138801 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [TBL] [Abstract][Full Text] [Related]
3. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902 [TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications. Cantor Sackett J; Weller RA; Weller EB Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288 [TBL] [Abstract][Full Text] [Related]
5. The use of selective serotonin reuptake inhibitors in pregnancy. Wen SW; Walker M J Obstet Gynaecol Can; 2004 Sep; 26(9):819-22. PubMed ID: 15361279 [TBL] [Abstract][Full Text] [Related]
6. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis. Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100 [TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis. Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040 [TBL] [Abstract][Full Text] [Related]
8. The use of antidepressants in pregnancy: focus on maternal risks. Gadot Y; Koren G J Obstet Gynaecol Can; 2015 Jan; 37(1):56-63. PubMed ID: 25764038 [TBL] [Abstract][Full Text] [Related]
9. Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence. Alwan S; Friedman JM; Chambers C CNS Drugs; 2016 Jun; 30(6):499-515. PubMed ID: 27138915 [TBL] [Abstract][Full Text] [Related]
10. Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. Alwan S; Bandoli G; Chambers CD Clin Pharmacol Ther; 2016 Jul; 100(1):34-41. PubMed ID: 27060574 [TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects. Ornoy A; Koren G Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):247-259. PubMed ID: 29345153 [TBL] [Abstract][Full Text] [Related]
12. Fetal and neonatal effects of maternal drug treatment for depression. Belik J Semin Perinatol; 2008 Oct; 32(5):350-4. PubMed ID: 18929158 [TBL] [Abstract][Full Text] [Related]
14. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715 [TBL] [Abstract][Full Text] [Related]
15. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy. Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692 [TBL] [Abstract][Full Text] [Related]
16. Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. Wichman CL; Moore KM; Lang TR; St Sauver JL; Heise RH; Watson WJ Mayo Clin Proc; 2009; 84(1):23-7. PubMed ID: 19121250 [TBL] [Abstract][Full Text] [Related]
17. Safety of newer antidepressants in pregnancy. Way CM Pharmacotherapy; 2007 Apr; 27(4):546-52. PubMed ID: 17381382 [TBL] [Abstract][Full Text] [Related]
18. What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence. Womersley K; Ripullone K; Agius M Psychiatr Danub; 2017 Sep; 29(Suppl 3):629-644. PubMed ID: 28953843 [TBL] [Abstract][Full Text] [Related]
19. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. Grigoriadis S; Vonderporten EH; Mamisashvili L; Tomlinson G; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE BMJ; 2014 Jan; 348():f6932. PubMed ID: 24429387 [TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. Kieler H; Artama M; Engeland A; Ericsson O; Furu K; Gissler M; Nielsen RB; Nørgaard M; Stephansson O; Valdimarsdottir U; Zoega H; Haglund B BMJ; 2012 Jan; 344():d8012. PubMed ID: 22240235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]